NCT03260842 Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
| NCT ID | NCT03260842 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Pancreatic Cyst |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-09-01 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-09-01 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.
Eligibility Criteria
Inclusion Criteria: * Older than 18 with pancreas cyst * Older than 18 at high risk for Pancreas cancer Exclusion Criteria: * Unable to provide consent * Not willing to provide bio-specimens
Contact & Investigator
Walter Park, MD
PRINCIPAL INVESTIGATOR
Faculty
Frequently Asked Questions
Who can join the NCT03260842 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cyst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03260842 currently recruiting?
Yes, NCT03260842 is actively recruiting participants. Contact the research team at wgpark@stanford.edu for enrollment information.
Where is the NCT03260842 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT03260842 clinical trial?
NCT03260842 is sponsored by Stanford University. The principal investigator is Walter Park, MD at Faculty. The trial plans to enroll 500 participants.